Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$66.6M Sell
829,393
-12,289
-1% -$985K 2.07% 8
2019
Q2
$67.3M Sell
841,682
-57,110
-6% -$4.37M 2.17% 8
2019
Q1
$71.3M Buy
898,792
+136,100
+18% +$10.2M 2.43% 5
2018
Q4
$55.6M Buy
762,692
+264,798
+53% +$18.7M 2.18% 5
2018
Q3
$33.7M Buy
497,894
+416,645
+513% +$26.5M 1.09% 17
2018
Q2
$4.71M Buy
81,249
+21,396
+36% +$1.21M 0.16% 127
2018
Q1
$3.11M Buy
59,853
+5,049
+9% +$273K 0.11% 164
2017
Q4
$2.94M Buy
54,804
+4,911
+10% +$272K 0.11% 164
2017
Q3
$3.05M Sell
49,893
-62,090
-55% -$3.76M 0.11% 154
2017
Q2
$6.85M Sell
111,983
-68,407
-38% -$4.16M 0.26% 79
2017
Q1
$10.9M Buy
180,390
+6,986
+4% +$424K 0.43% 51
2016
Q4
$9.74M Buy
+173,404
New +$10.1M 0.44% 51

Other funds holding MRK

Neuburgh Advisers's MRK Position: Q3 2019 in Review

Neuburgh Advisers reduced its Merck (MRK) stake by 1.5% in Q3 2019, selling an estimated $985K and leaving 829,393 shares worth $66.6M. The position accounts for 2.07% of the portfolio, ranked #8.

Neuburgh Advisers first reported a position in MRK in Q4 2016 and has held it in 12 quarters since. The position peaked at $71.3M in Q1 2019. 2,305 funds tracked by Wall St. Rank hold MRK as of Q3 2019.

  • Neuburgh Advisers held 829,393 shares of Merck worth $66.6M as of Q3 2019.
  • Neuburgh Advisers sold 12,289 Merck shares in Q3 2019, an estimated $985K.
  • Merck made up 2.07% of Neuburgh Advisers's portfolio in Q3 2019, its #8 holding.
  • Neuburgh Advisers first reported a position in Merck in Q4 2016 and has held it in 12 quarters since.
  • Neuburgh Advisers's Merck position peaked at $71.3M in Q1 2019.
  • 2,305 funds tracked by Wall St. Rank held Merck as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.